Dld Asset Management, LP Entera Bio Ltd. Transaction History

Dld Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.84 - $2.97 $678,960 - $1.1 Million	-369,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.11 - $3.75 $932 - $1,657	-442 Reduced 0.12%	369,000 $919,000
Q2 2019 Aug 14, 2019	BUY	$2.92 - $4.4 $109,254 - $164,630	37,416 Added 11.27%	369,442 $1.27 Million
Q1 2019 May 14, 2019	BUY	$3.01 - $4.84 $80,969 - $130,196	26,900 Added 8.82%	332,026 $1.44 Million
Q4 2018 Feb 13, 2019	BUY	$3.0 - $5.85 $75,042 - $146,331	25,014 Added 8.93%	305,126 $931,000
Q3 2018 Nov 13, 2018	BUY	$4.5 - $6.7 $142,254 - $211,800	31,612 Added 12.72%	280,112 $1.63 Million
Q2 2018 Aug 14, 2018	BUY	$6.28 - $6.3 $1.56 Million - $1.57 Million	248,500 New	248,500 $1.57 Million

5.34M

2.6K

100

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $49.8M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.